---
title: Next-generation sequencing RNA fusion panel for the diagnosis of haematological
  malignancies
date: '2024-12-13'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39672769/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20241214171558&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Haematological malignancies are being increasingly defined by gene rearrangements,
  which have traditionally been detected by karyotype, fluorescent in situ hybridisation
  (FISH) or reverse-transcriptase polymerase chain reaction (RT-PCR). However, these
  traditional methods may miss cryptic gene rearrangements and are limited by the
  number of gene rearrangements screened at any one time. A next-generation sequencing
  (NGS) RNA fusion panel is an evolving technology that can identify multiple ...
disable_comments: true
---
Haematological malignancies are being increasingly defined by gene rearrangements, which have traditionally been detected by karyotype, fluorescent in situ hybridisation (FISH) or reverse-transcriptase polymerase chain reaction (RT-PCR). However, these traditional methods may miss cryptic gene rearrangements and are limited by the number of gene rearrangements screened at any one time. A next-generation sequencing (NGS) RNA fusion panel is an evolving technology that can identify multiple ...